BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
26 results:

  • 1. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    Okuno K; Ikemura K; Okamoto R; Oki K; Watanabe A; Kuroda Y; Kidachi M; Fujino S; Nie Y; Higuchi T; Chuman M; Washio M; Sakuraya M; Niihara M; Kumagai K; Sangai T; Kumamoto Y; Naitoh T; Hiki N; Yamashita K
    PLoS One; 2024; 19(4):e0299827. PubMed ID: 38557819
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse model.
    Choi Y; Lee HK; Ahn D; Nam MW; Go RE; Choi KC
    Life Sci; 2023 Sep; 328():121866. PubMed ID: 37331506
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of an lncRNA model for prognostic prediction of bladder cancer.
    Shi C; Li Y; Wan E; Zhang E; Sun L
    BMC Med Genomics; 2022 Dec; 15(1):257. PubMed ID: 36514150
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Impact of Radiation Therapy in Pure Mucinous breast Carcinoma.
    Chevli N; Wang K; Haque W; Schwartz MR; Nangia J; Sasaki J; Farach AM; Hatch SS; Butler EB; Teh BS
    Clin Breast Cancer; 2022 Oct; 22(7):e807-e817. PubMed ID: 35915020
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Validation of common reference genes stability in exosomal mRNA-isolated from liver and breast cancer cell lines.
    Gorji-Bahri G; Moradtabrizi N; Vakhshiteh F; Hashemi A
    Cell Biol Int; 2021 May; 45(5):1098-1110. PubMed ID: 33501690
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Downregulated METTL14 Expression Correlates with breast cancer Tumor Grade and Molecular Classification.
    Dong XF; Wang Y; Huang BF; Hu GN; Shao JK; Wang Q; Tang CH; Wang CQ
    Biomed Res Int; 2020; 2020():8823270. PubMed ID: 33134390
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
    Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
    JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The relationship between anesthetic technique and thirty-day mortality in patients undergoing noncardiac- and nonneurosurgery: A retrospective, propensity score-matched cohort study.
    Luo X; Liu B; Li F; Zheng S; Li Y; Yang L; Gao R; Guo QY; Chen H; Huang K; Hu H; He J
    Int J Surg; 2020 May; 77():120-127. PubMed ID: 32234578
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
    Amelot A; Terrier LM; Cristini J; Buffenoir K; Pascal-Moussellard H; Carpentier A; Bonaccorsi R; Le Nail LR; Mathon B
    Eur J Surg Oncol; 2020 Jun; 46(6):1021-1027. PubMed ID: 31899046
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge.
    Veta M; Heng YJ; Stathonikos N; Bejnordi BE; Beca F; Wollmann T; Rohr K; Shah MA; Wang D; Rousson M; Hedlund M; Tellez D; Ciompi F; Zerhouni E; Lanyi D; Viana M; Kovalev V; Liauchuk V; Phoulady HA; Qaiser T; Graham S; Rajpoot N; Sjöblom E; Molin J; Paeng K; Hwang S; Park S; Jia Z; Chang EI; Xu Y; Beck AH; van Diest PJ; Pluim JPW
    Med Image Anal; 2019 May; 54():111-121. PubMed ID: 30861443
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
    Guo Y; Yu P; Liu Z; Maimaiti Y; Chen C; Zhang Y; Yin X; Wang S; Liu C; Huang T
    PLoS One; 2017; 12(4):e0174843. PubMed ID: 28394898
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
    Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
    [No Abstract]    [Full Text] [Related]  

  • 13. MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.
    Bertoli G; Cava C; Diceglie C; Martelli C; Rizzo G; Piccotti F; Ottobrini L; Castiglioni I
    Breast Cancer Res Treat; 2017 Feb; 161(3):605-616. PubMed ID: 28000015
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pregnancy-Associated Risk Factors of Postpartum breast cancer in Korea: A Nationwide Health Insurance Database Study.
    Kang EJ; Seo JH; Kim LY; Park GU; Oh MJ; Park PJ; Cho GJ
    PLoS One; 2016; 11(12):e0168469. PubMed ID: 27977789
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
    Markkula A; Simonsson M; Ingvar C; Rose C; Jernström H
    BMC Cancer; 2014 Oct; 14():759. PubMed ID: 25305747
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor-associated macrophages are correlated with tamoxifen resistance in the postmenopausal breast cancer patients.
    Xuan QJ; Wang JX; Nanding A; Wang ZP; Liu H; Lian X; Zhang QY
    Pathol Oncol Res; 2014 Jul; 20(3):619-24. PubMed ID: 24414992
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
    Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
    Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules.
    Teschendorff AE; Gomez S; Arenas A; El-Ashry D; Schmidt M; Gehrmann M; Caldas C
    BMC Cancer; 2010 Nov; 10():604. PubMed ID: 21050467
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.
    Phillips KA; Milne RL; West DW; Goodwin PJ; Giles GG; Chang ET; Figueiredo JC; Friedlander ML; Keegan TH; Glendon G; Apicella C; O'Malley FP; Southey MC; Andrulis IL; John EM; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1792-7. PubMed ID: 19505912
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.